Bruker BioSciences Corporation Files Definitive Proxy with the SEC, Including Proposals for Acquisition of Bruker Optics
BILLERICA, Mass.--(BUSINESS WIRE)--May 25, 2006--
Bruker BioSciences Corporation (Nasdaq: BRKR) announced today that it has filed a definitive proxy statement with the Securities and Exchange Commission for its annual meeting of shareholders, which includes proposals relating to shareholder approval of its proposed acquisition of Bruker Optics Inc.
ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR)
Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science, materials research, and industrial X-ray analysis tools. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com.
CONTACT:
Bruker BioSciences Corporation
Michael Willett, 978-663-3660, ext. 1411
Michael.Willett@bruker.com
SOURCE:
Bruker BioSciences Corporation
